-
EP2566978
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2566978
| EP2566978 - ANTIVIRAL TREATMENT SUSCEPTIBILITY GENE AND USES THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 14.04.2017 Database last updated on 18.11.2024 | |
| Former | Request for examination was made Status updated on 02.01.2017 | Most recent event Tooltip | 14.04.2017 | Application deemed to be withdrawn | published on 17.05.2017 [2017/20] | Applicant(s) | For all designated states Université d'Aix-Marseille Jardin Pharo 58 boulevard Charles Livon 13007 Marseille 7 / FR | [2013/11] | Inventor(s) | 01 /
DESSEIN, Alain 19 avenue du Vallon F-13009 Marseille / FR | [2013/11] | Representative(s) | Chajmowicz, Marion, et al Becker & Associés 25, Rue Louis Le Grand 75002 Paris / FR | [N/P] |
| Former [2013/11] | Chajmowicz, Marion, et al Becker & Associés 25 rue Louis le Grand 75002 Paris / FR | Application number, filing date | 11718356.6 | 04.05.2011 | WO2011EP57145 | Priority number, date | US20100331060P | 04.05.2010 Original published format: US 331060 P | [2013/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011138370 | Date: | 10.11.2011 | Language: | EN | [2011/45] | Type: | A1 Application with search report | No.: | EP2566978 | Date: | 13.03.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.11.2011 takes the place of the publication of the European patent application. | [2013/11] | Search report(s) | International search report - published on: | EP | 10.11.2011 | Classification | IPC: | C12Q1/68 | [2013/11] | CPC: |
C12Q1/6883 (EP,US);
C12Q1/6876 (US);
C12Q2600/106 (EP,US);
C12Q2600/156 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/11] | Title | German: | SUSZEPTILITÄTSGEN FÜR ANTIVIRALE BEHANDLUNG UND SEINE VERWENDUNG | [2013/11] | English: | ANTIVIRAL TREATMENT SUSCEPTIBILITY GENE AND USES THEREOF | [2013/11] | French: | GÈNE DE SUSCEPTIBILITÉ À UN TRAITEMENT ANTIVIRAL ET SES UTILISATIONS | [2013/11] | Entry into regional phase | 08.11.2012 | National basic fee paid | 08.11.2012 | Designation fee(s) paid | 08.11.2012 | Examination fee paid | Examination procedure | 08.11.2012 | Amendment by applicant (claims and/or description) | 08.11.2012 | Examination requested [2013/11] | 01.12.2016 | Application deemed to be withdrawn, date of legal effect [2017/20] | 03.01.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2017/20] | Fees paid | Renewal fee | 03.05.2013 | Renewal fee patent year 03 | 26.05.2014 | Renewal fee patent year 04 | 21.05.2015 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.05.2016 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Licence(s) | ID: | 01 01/exclusive | For: | AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR | Licencee: | Genepred Biotechnologies 19 avenue du vallon 13009 Marseille / FR | Date: | 09.07.2015 | [2015/44] | Cited in | International search | [I] - TSENG KUO-CHIH ET AL, "Prognostic Effect of Human Leukocyte Antigen Class I and II Alleles on Chronic Hepatitis C Patients Treated by Pegylated Interferon-Alfa Plus Ribavirin in Taiwan", HEPATO-GASTROENTEROLOGY, THIEME, STUTTGART, DE, (20100501), vol. 57, no. 99-100, ISSN 0172-6390, pages 456 - 461, XP008137665 [I] 1-19 * the whole document * | [A] - DESSEIN ALAIN ET AL, "Variants of CTGF are associated with hepatic fibrosis in Chinese, Sudanese, and Brazilians infected with Schistosomes", JOURNAL OF EXPERIMENTAL MEDICINE, (200910), vol. 206, no. 11, ISSN 0022-1007, pages 2321 - 2328, XP002640749 [A] 1-19 * the whole document * | [A] - DESSEIN A J ET AL, "Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene", AMERICAN JOURNAL OF HUMAN GENETICS, AMERICAN SOCIETY OF HUMAN GENETICS, CHICAGO, IL, US, (19990901), vol. 65, no. 3, doi:DOI:10.1086/302526, ISSN 0002-9297, pages 709 - 721, XP002526206 [A] 1-19 * the whole document * DOI: http://dx.doi.org/10.1086/302526 | [A] - BLANTON RONALD E ET AL, "Schistosomal hepatic fibrosis and the interferon gamma receptor: a linkage analysis using single-nucleotide polymorphic markers", EUROPEAN JOURNAL OF HUMAN GENETICS, KARGER, BASEL, CH, (20050501), vol. 13, no. 5, doi:DOI:10.1038/SJ.EJHG.5201388, ISSN 1018-4813, pages 660 - 668, XP002526202 [A] 1-19 * the whole document * DOI: http://dx.doi.org/10.1038/SJ.EJHG.5201388 | [A] - BACKUS LISA I ET AL, "Predictors of Sustained Virologic Response to Pegylated Interferon and Ribavirin in a National Cohort of Male HIV/HCV-Coinfected Veterans in Routine Medical Care", GASTROENTEROLOGY, & DIGESTIVE DISEASE WEEK/110TH ANNUAL MEETING OF THE AMERICAN-GASTROENTEROLOGICAL-ASSOCIATION; CHICAGO, IL, USA; MAY 30 JUNE 04, 2009, (200905), vol. 136, no. 5, Suppl. 1, ISSN 0016-5085, page A837, XP002640750 [A] 1-19 * the whole document * | [A] - BLOM I E ET AL, "Identification of human ccn2 (connective tissue growth factor) promoter polymorphisms", MP. MOLECULAR PATHOLOGY, BMJ PUBLISHING GROUP, LONDON, GB, (20010601), vol. 54, no. 3, doi:DOI:10.1136/MP.54.3.192, ISSN 1366-8714, pages 192 - 196, XP002526205 [A] 1-19 * the whole document * DOI: http://dx.doi.org/10.1136/mp.54.3.192 | [A] - GRESSNER OLAV A ET AL, "Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases", LIVER INTERNATIONAL, BLACKWELL MUNKSGAARD, OXFORD, GB, (20080901), vol. 28, no. 8, doi:DOI:10.1111/J.1478-3231.2008.01826.X, ISSN 1478-3223, pages 1065 - 1079, XP009115888 [A] 1-4,8-19 * the whole document * DOI: http://dx.doi.org/10.1111/j.1478-3231.2008.01826.x | [AP] - APARCIO E ET AL, "IL28B SNP rs8099917 is strongly associated with pegylated interferon-alpha and ribavirin therapy treatment failure in HCV-HIV-1-coinfected patients", ANTIVIRAL THERAPY; WORKSHOP ON INTERNATIONAL HIV AND HEPATITIS VIRUS DRUG RESISTANCE AND CURATIVE STRATEGIES; DUBROVNIK, CROATIA; JUNE 08 20100608 MTM PUBLICATIONS, LONDON, GB, (20100608), vol. 15, no. supplement 2, ISSN 1359-6535, page A119, XP008137662 [AP] 1-19 * the whole document * | [A] - SCHUPPAN D ET AL, "Hepatitis C and liver fibrosis", CELL DEATH AND DIFFERENTIATION, NATURE PUBLISHING GROUP, GB, (20030101), vol. 10, no. supplement 1, doi:DOI:10.1038/SJ.CDD.4401163, ISSN 1350-9047, pages S59 - S67, XP008137658 [A] 1-19 * the whole document * DOI: http://dx.doi.org/10.1038/sj.cdd.4401163 | by applicant | WO0050639 | US2005282179 | - CZAJA A, FREESE DK, "Diagnosis and Treatment of Autoimmune hepatitis", HEPATOLOGY, (2003), pages 473 - 496 | - POUPON RE, LINDOR KD, CAUCH-DUDEK K ET AL., "Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis", GASTROENTEROLOGY, (1997), pages 113 - 884 | - BRUCK R, SHIRIN H, HERSHKOVIZ R ET AL., "Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice", GUT, (1997), vol. 40, page 133 | - SCHUPPAN D, KREBS A, BAUER M, HAHN EG, "Hepatitis C and liver fibrosis", CELL DEATH AND DIFFERENCIATION, (2003), vol. 10, pages S59 - S67 | - NATHAN DG, ORKIN SH, "Musings and genome medicine: Hepatitis C", GENOME MEDICINE, (2010), vol. 2, page 4 | - FRIED MW, "Side effects of therapy of Hepatitis C and their management", HEPATOLOGY, (2002), vol. 36, no. 5, page 1 |